Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-31
1996-05-21
Criares, T. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514359, 514365, 514367, 514372, 514373, 514374, 514375, 514378, 514384, 514394, 514399, 514415, 514438, 514427, 514406, 514655, 514603, 514628, 514629, 514699, 514443, 514446, 514306, 514308, A61K 3144, A61K 3141, A61K 31425, A61K 3142, A61K 31415, A61K 31405, A61K 3138, A61K 3140, A61K 3113, A61K 3118, A61K 3116, A61K 3111
Patent
active
055190332
ABSTRACT:
The present invention relates to a method of treating urinary incontinence in mammals, including humans, using certain quinuclidine derivatives, piperidine derivatives, azanorbornane derivatives of azabiaglo and related compounds.
REFERENCES:
Remington's Pharmaceutical Science, 16th Edition, Mack Publishing Co., 1980 pp. 420-427.
Desai Manoj C.
Lowe, III John A.
Rosen Terry J.
Criares T. J.
DeBenedictis Karen
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Azabicyclo derivatives for treatment of urinary incontinence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azabicyclo derivatives for treatment of urinary incontinence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabicyclo derivatives for treatment of urinary incontinence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2038309